SaNOtize Research & Development Corp., (“SaNOtize”), a Canadian anti-infective-focused therapeutics company, today announced an oversubscribed…
pthomsonSeptember 2, 2022
News and Articles
Dr. Philip Hieter (pictured) from UBC received a Canadian Institutes of Health Research grant to…
pthomsonSeptember 1, 2022
In a recent publication, researchers in Dr. Peter Zandstra's lab developed a clinically relevant process…
pthomsonAugust 31, 2022
As a clinician, investigator and director of the Vaccine Evaluation Center (VEC) at BC Children’s Hospital, Sauder…
pthomsonAugust 30, 2022
A sun-lit Vancouver building houses a world-renowned team of scientists and researchers. They are oncologists,…
sciencecityApril 3, 2019
If you, loved ones or friends suffer from diseases that may involve abnormal blood clotting,…
sciencecityApril 3, 2019
Tuberculosis (TB) is the world’s deadliest infectious killer but a team of SFU-led researchers is…
sciencecityMarch 28, 2019
RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company…
sciencecityMarch 26, 2019
News and Articles
Viruses have evolved diverse strategies to evade the host innate immune response and promote infection.…
pthomsonAugust 15, 2023
UBC faculty of medicine researchers have been awarded $7 million in new funding to advance…
pthomsonAugust 14, 2023
Antivirals with broad coronavirus activity are important for treating high-risk individuals exposed to the constantly…
pthomsonAugust 14, 2023
Upcoming Events in Vancouver
Stay up-to-date with all of the life science events taking place in Vancouver with the Science in Vancouver events calendar!
